Study finds no link among estrogen and lung cancer mortality in postmenopausal women
Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online August 13 in The Journal of the National Cancer Institute. In the Women’s Health Initiative (WHI) trial, which consisted of several clinical trials on postmenopausal women, one study showed women with previous hysterectomy taking combined estrogen plus progestin therapy had …
Related Post
- Genetic predictor of breast cancer response to chemotherapy - May 13th, 2012
- Genetic Technologies Executes Settlement and License Agreement With GeneSeek Inc. - May 13th, 2012
- Molecular subtypes and genetic alterations may determine response to lung cancer therapy - May 13th, 2012
- Gene therapy for hearing loss: Potential and limitations - May 13th, 2012
- New Genetic Discoveries and Treatment for Hepatitis C [Viewpoint] - May 13th, 2012
- Diagnosing a Rare, Genetic Disease - May 13th, 2012
- Interferon-alpha enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma - May 13th, 2012
- Zinc Finger Protein Designed to Target 2-Long Terminal Repeat Junctions Interferes with Human Immunodeficiency Virus Integration - May 13th, 2012
- A Shield Against Chemotherapy - May 13th, 2012
- Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome - May 13th, 2012
- A paradigm shift in the delivery of services for diagnosis of inherited retinal disease - May 13th, 2012
- Generational Achievements in Gene and Cell Therapy Honored at ASGCT 15th Annual Meeting - May 6th, 2012
- Lewis speaks on gene therapy at Lexington Community Education event - May 6th, 2012
- Gene therapy for HIV safe, but effectiveness still unclear - May 6th, 2012
- Gene Therapy Safe in Decade-Long HIV Study That May Widen Use - May 6th, 2012
- Study: Gene Therapy for HIV Safe, But Effectiveness Still Unclear - May 6th, 2012
- HIV Gene Therapy Safe Over Time (CME/CE) - May 6th, 2012
- Nanovector delivery of siRNA for cancer therapy - May 6th, 2012
- Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model - May 6th, 2012
- Interferon-? lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-? gene transfer to human tumor cells - May 6th, 2012
- MicroRNA silencing improves the tumor specificity of adenoviral transgene expression - May 6th, 2012
- Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC - May 6th, 2012
- Gene Hunt Is On for Mental Disabilities in Children - May 6th, 2012
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning - May 6th, 2012
- MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy - May 6th, 2012
- Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency - May 6th, 2012
- April 2012 Advances: Additional Resources - May 6th, 2012
- Huntington's disease: genetic disorder of cognitive and motor decline - May 6th, 2012
- Research and Markets: Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders - April 29th, 2012
- Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice - April 29th, 2012
- Epirubicin potentiates recombinant adeno?associated virus type 2/5–mediated TRAIL expression in fibroblast?like synoviocytes and augments the antiarthritic effects of rAAV2/5?TRAIL - April 29th, 2012
- CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results - April 29th, 2012
- Prospects for gene transfer for clinical heart failure - April 29th, 2012
- Gene therapy for ventricular tachyarrhythmias - April 29th, 2012
- Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection - April 29th, 2012
- IL15 combined with Caspy2 provides enhanced therapeutic efficiency against murine malignant neoplasm growth and metastasis - April 29th, 2012
- A Herpesvirus saimiri-based vector expressing TRAIL induces cell death in human carcinoma cell lines and multicellular spheroid cultures. - April 29th, 2012
- Calcium carbonate microparticles used as a gene vector for delivering p53 gene into cancer cells. - April 29th, 2012
- A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications - April 29th, 2012
- Global Gene Therapy Industry - April 22nd, 2012
- Lab Notes: Skin Cancer Spread Tied to Gene - April 22nd, 2012
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice - April 22nd, 2012
- Innovative Methods for Improving Measures of the Personal Environment - April 22nd, 2012
- Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-? - April 22nd, 2012
- Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior - April 22nd, 2012
- Direct conversion in the heart: a simple twist of fate - April 22nd, 2012
- [World Report] Promising new era dawns for cystic fibrosis treatment - April 22nd, 2012
- British Society for Gene Therapy 2012; March 9, 2012; UCL Institute of Child Health, London - April 22nd, 2012
- Treatment of a Solid Tumor Using Engineered Drug-Resistant Immunocompetent Cells and Cytotoxic Chemotherapy - April 22nd, 2012
- Genetic Technologies' Subsidiary Update - April 15th, 2012
